Abdul-Aziz M.M. El-Attar

Synthesis and antibacterial evaluation of a novel library of 2-(thiazol-5-yl)-1,3,4-oxadiazole derivatives against methicillin-resistant Staphylococcus aureus (MRSA)

Mohamed H. Hannoun, Mohamed Hagras, Ahmed Kotb et al. · Bioorganic Chemistry · 2019 · 49 citations

Pharmacy, Medicinal Chemistry, Pharmacology +12

Ligand and Structure-Based In Silico Determination of the Most Promising SARS-CoV-2 nsp16-nsp10 2′-o-Methyltransferase Complex Inhibitors among 3009 FDA Approved Drugs

Ibrahim H. Eissa, Mohamed S. Alesawy, Abdulrahman M. Saleh et al. · Molecules · 2022 · 49 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Structure-Based Virtual Screening, Docking, ADMET, Molecular Dynamics, and MM-PBSA Calculations for the Discovery of Potential Natural SARS-CoV-2 Helicase Inhibitors from the Traditional Chinese Medicine

Ahmed M. Metwaly, Alaa Elwan, Abdul-Aziz M.M. El-Attar et al. · Journal of Chemistry · 2022 · 28 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Computational design for eco-friendly visible spectrophotometric platform used for the assay of the antiviral agent in pharmaceutical dosage form

Ahmed Elsonbaty, Ahmed W. Madkour, Ahmed M. Abdel‐Raoof et al. · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · 2022 · 25 citations

Pharmacy, Pharmaceutical Analysis, Pharmaceutics +13

The Discovery of Potential SARS-CoV-2 Natural Inhibitors among 4924 African Metabolites Targeting the Papain-like Protease: A Multi-Phase In Silico Approach

Eslam B. Elkaeed, Mohamed M. Khalifa, Bshra A. Alsfouk et al. · Metabolites · 2022 · 16 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12